Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC 1000 methodology specified in sections 1833(o) and 1834(h) of the Act. Section 627 of the MMA amended section 1833(o)(2) of the Act to require implementation of fee schedule amounts, effective January 1, 2005, for the purpose of determining payment for custom molded shoes, extra-depth shoes, and inserts (collectively, “therapeutic shoes”). Section 627 of the MMA was initially implemented through program instructions, and on January 1, 2005, Medicare began paying for therapeutic shoes, inserts, and shoe modifications based on fee schedule amounts determined in accordance with section 1834(h) of the Act and 42 CFR part 414, subpart D of our regulations. We did not receive any comments on our proposal to add §414.228(c) to 42 CFR part 414, subpart D of our regulations. Therefore, we are finalizing proposed §414.228(c) regarding the methodology used to establish fee schedule amounts for therapeutic shoes, inserts and shoe modifications.
CMS-1403-FC XII. Provisions of the Final Rule The provisions of this final rule with comment period restate the provisions of the CY 2009 PFS proposed rule, except as noted elsewhere in the preamble. XIII. Waiver of Proposed Rulemaking and Delay in Effective Date We ordinarily publish a notice of proposed rulemaking in the Federal Register and invite public comment on the proposed rule. The notice of proposed rulemaking includes a reference to the legal authority under which the rule is proposed, and the terms and substances of the proposed rule or a description of the subjects and issues involved. This procedure can be waived, however, if an agency finds good cause that a notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and incorporates a statement of the finding and its reasons in the rule issued. We utilize HCPCS codes for Medicare payment purposes. The HCPCS is a national drug coding system comprised of Level I (CPT) codes and Level II (HCPCS National Codes) that are intended to provide uniformity to coding procedures, services, and supplies across all types of medical providers and suppliers. Level I (CPT) codes are copyrighted by the AMA and consist of several categories, 1001
- Page 949 and 950: CMS-1403-FC C. The Update Adjustmen
- Page 951 and 952: CMS-1403-FC end of the prior year a
- Page 953 and 954: CMS-1403-FC CY 2009, the statute re
- Page 955 and 956: CMS-1403-FC Actual08 = Estimated Ac
- Page 957 and 958: CMS-1403-FC 1848(f)(3)(C)(i) of the
- Page 959 and 960: CMS-1403-FC ● Screening mammograp
- Page 961 and 962: CMS-1403-FC payments while promotin
- Page 963 and 964: CMS-1403-FC E. Final Sustainable Gr
- Page 965 and 966: CMS-1403-FC included in the SGR (us
- Page 967 and 968: CMS-1403-FC that this figure will c
- Page 969 and 970: CMS-1403-FC physicians' services in
- Page 971 and 972: CMS-1403-FC imaging services, the M
- Page 973 and 974: CMS-1403-FC CY 2007. Table 42 illus
- Page 975 and 976: CMS-1403-FC year to the entire year
- Page 977 and 978: CMS-1403-FC the CF. Therefore, this
- Page 979 and 980: CMS-1403-FC estimate that CY 2009 R
- Page 981 and 982: CMS-1403-FC Table 44: Calculation o
- Page 983 and 984: CMS-1403-FC XI. Payment for Certain
- Page 985 and 986: CMS-1403-FC In the Competitive Acqu
- Page 987 and 988: CMS-1403-FC glasses, hand magnifier
- Page 989 and 990: CMS-1403-FC Our interpretation of t
- Page 991 and 992: CMS-1403-FC Response: We understand
- Page 993 and 994: CMS-1403-FC defines “eyeglass”
- Page 995 and 996: CMS-1403-FC this statutory exclusio
- Page 997 and 998: CMS-1403-FC advances in the use of
- Page 999: CMS-1403-FC is paid for his or her
- Page 1003 and 1004: CMS-1403-FC these RUC recommendatio
- Page 1005 and 1006: CMS-1403-FC services. We believe a
- Page 1007 and 1008: CMS-1403-FC Section 144(b) of the M
- Page 1009 and 1010: CMS-1403-FC rulemaking with respect
- Page 1011 and 1012: CMS-1403-FC (respectively) of this
- Page 1013 and 1014: CMS-1403-FC completing and submitti
- Page 1015 and 1016: CMS-1403-FC §424.516(d)(1). Additi
- Page 1017 and 1018: CMS-1403-FC to several associated i
- Page 1019 and 1020: CMS-1403-FC incentive payment for 2
- Page 1021 and 1022: CMS-1403-FC year of PQRI reporting)
- Page 1023 and 1024: CMS-1403-FC Based on the assumption
- Page 1025 and 1026: CMS-1403-FC these activities for th
- Page 1027 and 1028: CMS-1403-FC per hour, we estimate t
- Page 1029 and 1030: CMS-1403-FC Because of the large nu
- Page 1031 and 1032: CMS-1403-FC threshold, and hence al
- Page 1033 and 1034: CMS-1403-FC shoes, the regulation i
- Page 1035 and 1036: CMS-1403-FC with comment period for
- Page 1037 and 1038: CMS-1403-FC substance of State laws
- Page 1039 and 1040: CMS-1403-FC $20 million from what e
- Page 1041 and 1042: CMS-1403-FC ● Impact of Work RVU
- Page 1043 and 1044: CMS-1403-FC imaging services from t
- Page 1045 and 1046: CMS-1403-FC ● Impact of section 1
- Page 1047 and 1048: CMS-1403-FC management, could have
- Page 1049 and 1050: CMS-1403-FC Table 50 illustrates, f
<strong>CMS</strong>-1403-FC<br />
XII. Provisions of the Final Rule<br />
The provisions of this final rule with comment period<br />
restate the provisions of the CY 2009 PFS proposed rule,<br />
except as noted elsewhere in the preamble.<br />
XIII. Waiver of Proposed Rulemaking and Delay in Effective<br />
Date<br />
We ordinarily publish a notice of proposed rulemaking<br />
in the Federal Register and invite public comment on the<br />
proposed rule. The notice of proposed rulemaking includes<br />
a reference to the legal authority under which the rule is<br />
proposed, and the terms and substances of the proposed rule<br />
or a description of the subjects and issues involved. <strong>This</strong><br />
procedure can be waived, however, if an agency finds good<br />
cause that a notice-and-comment procedure is impracticable,<br />
unnecessary, or contrary to the public interest and<br />
incorporates a statement of the finding and its reasons in<br />
the rule issued.<br />
We utilize HCPCS codes for Medicare payment purposes.<br />
The HCPCS is a national drug coding system comprised of<br />
Level I (CPT) codes and Level II (HCPCS National Codes)<br />
that are intended to provide uniformity to coding<br />
procedures, services, and supplies across all types of<br />
medical providers and suppliers. Level I (CPT) codes are<br />
copyrighted by the AMA and consist of several categories,<br />
1001